BioCentury | Dec 2, 2020
Regulation

Dec. 1 Quick Takes: broader label for Blueprint; plus Minerva, Biohaven-Sosei, Genetron, PegBio, drug imports

...deaths and the product profiles of blood-based cancer screening tests could accelerate the technology's commercial adoption.PegBio...
...TARGETSCGRP – Calcitonin gene-related peptide BC Staff Genetron Health PegBio Minerva Neurosciences Blueprint Medicines Biohaven Pharmaceutical Holding Co. Ltd. Sosei Group Corp. drug imports pegbio...
BioCentury | Sep 3, 2019
Clinical News

Sept. 3 Clinical Quick Takes: Phase II failure for Aridis, plus Kura, Idorsia, Concert, PegBio

...$0.94 to $11.01 on Tuesday. PegBio to start U.S. Phase I for long-acting NASH therapy PegBio Co. Ltd....
...and Hongjiang Li, Staff Writers Aerucin (AR-105) CTP-543 PB-718 selatogrel (ACT-246475) tipifarnib (zarnestra, R115777) Aridis Pharmaceuticals Inc. Concert Pharmaceuticals Inc. Idorsia Ltd. Kura Oncology Inc. PegBio Co. Ltd. Glucagon...
BioCentury | Jul 21, 2017
Financial News

Tasly invests in PegBio's series E round

...amount. Existing investor Legend Star also invested in the round, which Xu said he hopes PegBio...
...diabetes. Xu said Phase II testing is expected to start "soon." PegBio Co. Ltd. , Suzhou, China Chris Lieu PegBio Co. Ltd....
BioCentury | Jul 18, 2017
Financial News

Tasly invests in PegBio's series E round

...amount. Existing investor Legend Star also invested in the round, which Xu said he hopes PegBio...
...to treat Type II diabetes. Xu said Phase II testing is expected to start "soon." PegBio's...
...BioCentury Extra, Dec. 13, 2016) . Legend Star had previously invested $2 million in PegBio. Chris Lieu PB-119 PegBio Co. Ltd. Tasly...
BioCentury | Dec 15, 2016
Company News

Pfizer, PegBio deal

...Pfizer granted PegBio exclusive rights in Taiwan and China, including Hong Kong and Macau, to an...
...respond to inquiries. Pfizer Inc. (NYSE:PFE), New York, N.Y. PegBio Co. Ltd. , Suzhou, China Business: Endocrine/Metabolic Nora Weintraub PegBio Co. Ltd. Pfizer...
BioCentury | Dec 13, 2016
Company News

PegBio, Pfizer form diabetes partnership in China

...Pfizer Inc. (NYSE:PFE) granted PegBio Co. Ltd. (Suzhou, China) rights in Greater China to a glucokinase ( GCK...
...advance medicines addressing unmet needs. The partners did not respond to inquiries about the program. PegBio...
...to form additional local partnerships in China to support innovative drug development in the region. Becky Simon PegBio Co. Ltd. Pfizer...
Items per page:
1 - 6 of 6
BioCentury | Dec 2, 2020
Regulation

Dec. 1 Quick Takes: broader label for Blueprint; plus Minerva, Biohaven-Sosei, Genetron, PegBio, drug imports

...deaths and the product profiles of blood-based cancer screening tests could accelerate the technology's commercial adoption.PegBio...
...TARGETSCGRP – Calcitonin gene-related peptide BC Staff Genetron Health PegBio Minerva Neurosciences Blueprint Medicines Biohaven Pharmaceutical Holding Co. Ltd. Sosei Group Corp. drug imports pegbio...
BioCentury | Sep 3, 2019
Clinical News

Sept. 3 Clinical Quick Takes: Phase II failure for Aridis, plus Kura, Idorsia, Concert, PegBio

...$0.94 to $11.01 on Tuesday. PegBio to start U.S. Phase I for long-acting NASH therapy PegBio Co. Ltd....
...and Hongjiang Li, Staff Writers Aerucin (AR-105) CTP-543 PB-718 selatogrel (ACT-246475) tipifarnib (zarnestra, R115777) Aridis Pharmaceuticals Inc. Concert Pharmaceuticals Inc. Idorsia Ltd. Kura Oncology Inc. PegBio Co. Ltd. Glucagon...
BioCentury | Jul 21, 2017
Financial News

Tasly invests in PegBio's series E round

...amount. Existing investor Legend Star also invested in the round, which Xu said he hopes PegBio...
...diabetes. Xu said Phase II testing is expected to start "soon." PegBio Co. Ltd. , Suzhou, China Chris Lieu PegBio Co. Ltd....
BioCentury | Jul 18, 2017
Financial News

Tasly invests in PegBio's series E round

...amount. Existing investor Legend Star also invested in the round, which Xu said he hopes PegBio...
...to treat Type II diabetes. Xu said Phase II testing is expected to start "soon." PegBio's...
...BioCentury Extra, Dec. 13, 2016) . Legend Star had previously invested $2 million in PegBio. Chris Lieu PB-119 PegBio Co. Ltd. Tasly...
BioCentury | Dec 15, 2016
Company News

Pfizer, PegBio deal

...Pfizer granted PegBio exclusive rights in Taiwan and China, including Hong Kong and Macau, to an...
...respond to inquiries. Pfizer Inc. (NYSE:PFE), New York, N.Y. PegBio Co. Ltd. , Suzhou, China Business: Endocrine/Metabolic Nora Weintraub PegBio Co. Ltd. Pfizer...
BioCentury | Dec 13, 2016
Company News

PegBio, Pfizer form diabetes partnership in China

...Pfizer Inc. (NYSE:PFE) granted PegBio Co. Ltd. (Suzhou, China) rights in Greater China to a glucokinase ( GCK...
...advance medicines addressing unmet needs. The partners did not respond to inquiries about the program. PegBio...
...to form additional local partnerships in China to support innovative drug development in the region. Becky Simon PegBio Co. Ltd. Pfizer...
Items per page:
1 - 6 of 6